This pattern reflects the chronic, relapsing nature of obesity and has prompted the WHO to recommend continuous, long-term treatment lasting six months or moreeffectively positioning these medications as lifetime therapies for many patients [51]
People with type 2 diabetes and significant obesity (BMI 30) People with fatty liver disease (MASLD/MASH) People who haven't reached their goals with semaglutide or tirzepatide People with multiple metabolic conditions (diabetes, high blood pressure, high cholesterol, fatty liver) People who need more than 15-20% weight loss for health reasons When Will Retatrutide Be Available
It works by helping the body use insulin better, slowing digestion, and lowering appetite
Their joint consensus statement concluded that the existing literature indicates a possible small increased risk of NAION in patients taking semaglutide, but the risk remains low and is yet to be confirmed
While most individuals describe the sensation of a GLP-1 injection as a minor, fleeting discomfort, there are weeks where the experience can feel unexpectedly intense
